For the Quarter Ending September 2025
North America
• In United States, the Zidovudine Price Index rose quarter-over-quarter in Q3 2025, driven by escalating production costs.
• Zidovudine production costs increased due to a 2.6% year-over-year rise in PPI in August 2025.
• National health spending accelerated in 2025, outpacing GDP, supporting Zidovudine demand outlook.
• U.S. natural gas and retail electricity prices increased year-over-year in September 2025, raising manufacturing expenses.
• A 3.0% year-over-year CPI in September 2025 indicated moderate consumer inflation, affecting Zidovudine operational costs.
• U.S. pharmaceutical exports increased July-August 2025, while imports decreased, impacting Zidovudine trade flows.
• Industrial production showed near stagnation at 0.1% year-over-year in September 2025, affecting Zidovudine supply efficiency.
• Strong retail sales, up 5.42% year-over-year in September 2025, indirectly supported the healthcare ecosystem for Zidovudine.
• The Zidovudine Price Forecast points to continued upward pressure due to persistent input cost inflation and robust health spending.
Why did the price of Zidovudine change in September 2025 in North America?
• Producer Price Index rose 2.6% year-over-year in August 2025, increasing Zidovudine raw material costs.
• U.S. natural gas and retail electricity prices increased in September 2025, elevating Zidovudine production expenses.
• National health spending accelerated in 2025, supporting Zidovudine demand despite weak industrial production.
APAC
• Zidovudine Price Index fell in China, Q3 2025, due to declining costs and global overcapacity.
• Production costs for Zidovudine decreased in September 2025, due to a 2.3% PPI decline.
• Zidovudine demand outlook strong, fueled by aging population and rising healthcare expenditure.
• China's Industrial Production increased 6.5% in September 2025, supporting a stable economy.
• Retail sales grew 3.0% in September 2025, contributing to overall economic stability.
• Consumer Price Index declined 0.3% in September 2025, reflecting deflationary pressures.
• Manufacturing Index was Contracting in September 2025, signaling overall industrial activity slowdown.
• Consumer confidence index was 89.6 in September 2025, reflecting caution among consumers.
• China's pharmaceutical and API exports grew strongly in Q3 2025, showing robust demand.
• Unemployment rate was 5.2% in September 2025, indicating a stable labor market.
Why did the price of Zidovudine change in September 2025 in APAC?
• Producer Price Index declined 2.3% in September 2025, reducing Zidovudine production costs.
• Global overcapacity in chemical building blocks persisted in Q3 2025, exerting downward price pressure.
• Consumer Price Index declined 0.3% in September 2025, contributing to a deflationary market.
Europe
• In Germany, the Zidovudine Price Index fell quarter-over-quarter in Q3 2025, influenced by softening producer prices for the chemical industry.
• Zidovudine production costs faced upward pressure from a 2.4% CPI increase in September 2025, despite a -1.7% PPI decrease.
• Demand for Zidovudine strengthened in Q3 2025, driven by Germany's expanding pharmaceutical market and healthcare needs.
• The Manufacturing Index showed contracting industrial activity in September 2025, alongside a -1.0% industrial production decline.
• Overall chemical production in Germany declined in Q3 2025, with subdued capacity utilization, affecting Zidovudine supply.
• German pharmaceutical product imports increased markedly in Q3 2025, influencing domestic Zidovudine market dynamics.
• Elevated energy and raw material costs persisted in Q3 2025, despite stable European natural gas prices.
• A low 3.9% unemployment rate in September 2025 supported healthcare funding, positively impacting Zidovudine demand.
Why did the price of Zidovudine change in September 2025 in Europe?
• Softening producer prices for the German chemical industry in Q3 2025 reduced cost pressures.
• Increased German imports of pharmaceutical products in Q3 2025 intensified market competition.
• Elevated energy and raw material costs in Q3 2025 exerted upward pressure on Zidovudine production.
For the Quarter Ending December 2022
North America
In North America, Zidovudine's CFR Los Angeles pricing in the fourth quarter of 2022 rose from $568500/mt to $571000/mt in October and November before dipping to $566500/mt in December. Zidovudine imports were halted during the first week of October in China due to the country's Golden Week holiday.
Domestic suppliers were able to meet the overall demand for the majority of the quarter because of their large stocks, while offtakes in the end-user industries continued to be above normal. Due to the unexpected increase in Covid cases in China, the market for zidovudine underwent a pattern change in the second half of the quarter. Nevertheless, as the economy grew and there was a significant decline in port backlog in December, the disrupted supply chain did progressively mend.
Asia Pacific
In the Asia Pacific region, Zidovudine prices in China exhibited a stagnant market trend during the fourth quarter of 2022, with FOB Shanghai values showing a slight decrease from $517400/mt to $515500/mt in October and December. Due to the closure of manufacturing facilities for the Golden Week, Zidovudine orders for China's API sector steadily decreased during the first week of October. Because Chinese traders had to contend with a variety of conflicting signals following a one-week hiatus, it was difficult for the market to catch up to the modest increase witnessed in some downstream industries, but strong demand kept the market afloat. Sufficient stocks in China allowed domestic producers and suppliers to meet the total demand for the whole quarter. In reaction to criticism and severe turmoil in the country, the administration revised its zero-covid policies, making the country vulnerable yet again.
Europe
During the fourth quarter of 2022, Zidovudine prices declined somewhat in Europe, with CFR Hamburg values dropping from $590550/mt to $587550/mt between October and December. Due to the unanticipated rise in COVID cases, which led to a gradual fall in demand, international demand was higher in the first part of the quarter than it was in December. Despite increased energy and raw material costs, offtakes in the end-user industries remained high demand in Germany remained high.
For The Quarter Ending September 2022
North America
The North American region witnessed a stable pricing trend for Zidovudine API during the third quarter of 2022. The market saw a consistent decrement in upstream derivatives prices, which affected the prices for Zidovudine API in the North American region. With the commencement of the first month, the prices increased with increasing energy and surging crude oil costs. Further, higher freight charges affect the market's price value of zidovudine API. Later from the beginning of the second month till the termination of Q3, the price declined gradually with stabilizing demand from downstream demand. Truncated downstream demand with enough supply and ample stocks with the suppliers affected the cost of API further in Q3. With the termination of Q3, the prices for Zidovudine settled at USD 264500/MT CFR Los Angeles with an average quarterly declination of 1.34%.
Asia Pacific
During the third quarter of 2022, Zidovudine Market witnessed a declining trajectory in its prices in the APAC region owing to lowering derivatives ammonium prices. At the onset of Q3, the prices went down due to the weaker downstream demand. Further, the cost of Zidovudine drops down significantly in the last month of Q3, with an average decline of 1.62% in the domestic market. Furthermore, the rising inflation affected the consumer demand from the end-user industry to be weak, forcing domestic merchants and traders to lower their quotations in the domestic market. Altogether, the prices were assessed at USD 255340/MT FOB Shanghai.
Europe
The European market followed descending trajectory for the prices of Zidovudine during the third quarter of 2022. The prices went down due to lowering downstream demand from various end-users, mainly pharmaceutical industries. Further, enough existing inventories and stable supplies resulted in price decrement in the local and regional markets of the European region. Moreover, rising inflation prompted lower enquires and forced domestic merchants and traders to quote low prices. With the stable input cost and steady operational rates, the market sentiments were recorded to be feeble. Towards the termination of Q3, the fees were assessed at USD 261010/MT CFR Hamburg with an average quarterly declination of 4.89%.
For the Quarter Ending June 2022
North America
The North American region witnessed a stabled pricing trends for Zidovudine API during the second quarter of 2022. The market saw an consistent increment in upstream derivatives prices, which positively affected the prices for Zidovudine API. Increasing energy and surging crude oil cost resulted in higher freight charges, affecting the price value of zidovudine API in the market. Also, the trading activities were disrupted from various exporting countries resulting in higher freight charges and rerouting activity, positively affecting the price of API. Healthy downstream demand with lessened supply and reduced stocks with the suppliers affected the cost of API further. With the terminstion of Q2 the prices for Zidovudine settled at USD 275580/MT CFR Los Angeles.
Asia Pacific
During the second quarter of 2022, Zidovudine Market witnessed an upward pricing trajectory in its prices in the APAC region owing to higher derivatives ammonium prices. On the onset of Q2 the prices went down owing to weaker downstream demand. Further, The cost of Zidovudine raised significantly in the last month of q2 with an average inclination of 1.02% in the market. Furthermore, the trade disruption owing to the temporary shutdown of manufacturing units in China because of the lockdown in Shanghai and Beijing affected the market price of Zidovudine API in the region. Altogether, the prices were assessed at USD 268340/MT FOB Shanghai.
Europe
European market followed similar market sentiments in the prices of Zidovudine as in the North American region during the second quarter of 2022. The prices went high owing to higher downstream demand from various end-user, mainly pharmaceutical industries. Further, the traders' tightened supply and shortage of inventories resulted in the price enhancement in the local and regional markets. Moreover, substantial cost inflation in the drug prices also augmented API cost in the market. Also, the confrontation between Russia-Ukraine caused a rerouting activity leading to trade disruption and delayed shipment activities which affected API's price value in the market. Towards the termination of Q2 the prices were assessed at USD 303370/MT CFR Hamburg.
